Session Details

Global Regulatory Perspectives (GRP) Workshop Session 3 - Clinical Strategies for Treatment of Pediatric Diseases
Wednesday, May 29, 2019 12:45 PM - 02:00 PM
Room 218

Dominic Wall, PhD, FFSc(RCPA), Director of Pathology Operations, Peter MacCallum Cancer Center, Australia


Rachel Witten, MD, Lead Medical Officer, FDA, United States

I-Ning Tang, MD, MS, Section Chief of Regulatory Science, Taiwan Center for Drug Evaluation, Taiwan

Jaap Jan Boelens, MD, PhD, Pediatric Hematologic Oncologist, Chief of Stem Cell Transplantation and Cell Therapy Service, United States